COA Conference Coverage
Featured Articles
(AJMC Managed Markets Network) Apr 5, 2019 - The first day of the 2019 Community Oncology Conference, the major annual meeting of the Community Oncology Alliance (COA), featured an update on its effort to find alternatives to CMS' Oncology Care Model. After a year in development, the Community Oncology Alliance (COA) will file its...
Read Article
Latest Articles
April 08, 2019
April 05, 2019

OBR Tweets

Jan 27
William McGivney, PhD: The article (with totally ex-US authors) referred to was published in the British Medical Jo… https://t.co/6reunkPxAW

Jan 27
Howard S. Hochster, MD: Interesting but not overwhelming response rates, especially when compared with pretreated p… https://t.co/KFQMekfkeJ

Jan 25
Daniel Catenacci, MD, of @UChicagoMed elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020… https://t.co/SLFXcH9XHW

Jan 25
Manish Shah, MD, of @WeillCornell on the role of Cyramza in the treatment of gastric and esophageal cancers #GI20 https://t.co/83LT4SouTG

Jan 25
Daniel Catenacci, MD, of @UChicagoMed discusses margetuximab in the treatment of esophageal and gastric cancer #GI20 https://t.co/bKgtxzm0tl

Jan 25
Manish Shah, MD, of @WeillCornell regarding the use of liquid biopsy to diagnose and treat GI cancers #GI20 https://t.co/PgJcHQr2IZ

Jan 25
Sam Klempner, MD, of @harvardmed explains how circulating tumor DNA can be used to help determine therapy #GI20 https://t.co/xZwsm7PSW6

Jan 25
Hani Babiker, MD, of @UAZCancer elaborates on tumor treatment fields applying to GI malignancies #GI20 https://t.co/g8OENPsK7Y

Jan 25
Hani Babiker, MD, of @UAZCancer describes the setting of FDA approval on tumor treatment fields #GI20 https://t.co/Ytzc1MwAGM

Jan 25
Ahmed Kaseb, MD, of @MDAndersonNews on combining cabozantinib with checkpoint inhibitors for treatment of HCC #GI20 https://t.co/dd7RbGGru5